Trademark: 97602709
Word
LUMID
Status
Pending
Status Code
686
Status Date
Tuesday, May 21, 2024
Serial Number
97602709
Mark Type
4
Filing Date
Thursday, September 22, 2022
Published for Opposition
Tuesday, May 21, 2024

Trademark Owner History
SEED Therapeutics US, Inc. - Owner At Publication

Classifications
42 Pharmaceutical drug discovery services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials research; research and development of new products; providing scientific information, scientific, pharmaceutical, clinical, and medical research in the field of developing pharmaceutical drugs, drug discovery and development services, and consulting services with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell

Trademark Events
Sep 26, 2022
New Application Entered
Oct 9, 2022
New Application Office Supplied Data Entered
Jul 5, 2023
Assigned To Examiner
Jul 7, 2023
Non-Final Action Written
Jul 7, 2023
Non-Final Action E-Mailed
Jul 7, 2023
Notification Of Non-Final Action E-Mailed
Oct 5, 2023
Application Extension To Response Period - Received
Oct 5, 2023
Application Extension Granted/Receipt Provided
Jan 5, 2024
Teas Response To Office Action Received
Jan 5, 2024
Correspondence Received In Law Office
Jan 6, 2024
Teas/Email Correspondence Entered
Jan 8, 2024
Suspension Letter Written
Jan 8, 2024
Letter Of Suspension E-Mailed
Jan 8, 2024
Notification Of Letter Of Suspension E-Mailed
Apr 16, 2024
Approved For Pub - Principal Register
May 1, 2024
Notification Of Notice Of Publication E-Mailed
May 21, 2024
Published For Opposition
May 21, 2024
Official Gazette Publication Confirmation E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24